Should you post your research as a preprint? A balanced look at the visibility benefits, peer review concerns and reputational risks authors...
Should you post your research as a preprint? A balanced look at the visibility benefits, peer review concerns and reputational risks authors...
Phase I is the lifeblood or new medicines. The UK’s Phase I representative body,
Asthma is a chronic inflammatory disorder of the airways
There have been hundreds of thousands of deaths from COVID-19
The sudden imposition of remote working in response to the 2020 COVID-19
Phenotype-specific omic expression patterns in people with frailty could provid
The comparison of the DPP4 (dipeptidyl peptidase 4) SARS-CoV-2
In this case the plan is a paradigm shift in the way we will manage
The latest issue of Journal Frontiers in Pharmacology has just published
Our publication on effectiveness of a multimodal intervention
ive years ago I was lucky enough to be involved in a project that resulted in publications
Because new biologic treatments for asthma can be expensive and cause side effects,
Learn how to avoid plagiarism in scientific writing with practical tips, common pitfalls and proven techniques to protect your work.
The proceedings of the Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI)
A practical guide to responding to manuscript rejection with three steps and key tips for revising, rebutting reviewers, and resubmitting...
We all get them, some of us more than 10 a day, emails from journals
Our publication on the potential benefits of bariatric surgery
The first RASP-UK publication outlines a stratified medicine approach to severe asthma using biomarkers and personalised treatment...
Our publication on sarcoidosis, a multisystem inflammatory disease
10 warning signs of predatory journals and how researchers can protect their work from unethical publishers and poor peer review practices.
Our publication on new therapies in the management of type 2 diabetes mellitus
cientific knowledge is not created in isolation. Every new experiment, review article, dissertation, textbook chapter, or editorial builds...
ur publication on new therapies to reduce low-density
Our publication on the use of cardiovascular medication in women and continence
The progression of atherosclerosis, which is responsible for coronary heart disease
Today we had our manuscript on the pre-protein convertase subtilisin kexin (PCSK)-9
Epidemiological data suggest that at two in five of us will experience
Get our latest news and publications
Sign up to our news letter